July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Changes on the Optical Coherence Tomography Angiography (OCT-A) in newly diagnosed Type I diabetes patients. One year follow-up.
Author Affiliations & Notes
  • Anna Sala-Puigdollers
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Marc Figueras-Roca
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Carmen Alba-Linero
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Javier Zarranz-Ventura
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Vanessa Budi
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Monica Hernandez
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Alfredo Adan
    Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
  • Footnotes
    Commercial Relationships   Anna Sala-Puigdollers, None; Marc Figueras-Roca, None; Carmen Alba-Linero, None; Javier Zarranz-Ventura, None; Vanessa Budi, None; Monica Hernandez, None; Alfredo Adan, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3011. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anna Sala-Puigdollers, Marc Figueras-Roca, Carmen Alba-Linero, Javier Zarranz-Ventura, Vanessa Budi, Monica Hernandez, Alfredo Adan; Changes on the Optical Coherence Tomography Angiography (OCT-A) in newly diagnosed Type I diabetes patients. One year follow-up.. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3011.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine changes in the perifoveal vascular network measured by Optical Coherence Tomography Angiography (OCT-A) in Type I diabetic patients from diagnosis and insulin treatment start to one year follow-up.

Methods : Case series study of 26 eyes (13 patients) of newly diagnosed type I diabetes mellitus (DM) patients started on insulin therapy from August 2016 to June 2017. Patients who did not complete one year follow up were excluded from the study. A complete ophthalmological examination including 6x6 mm OCTA images captured with Angioplex (Cirrus, Carl-Zeiss Meditec Inc., Dublin, CA, USA) was carried out. Changes in the Foveal Avascular Zone (FAZ), vessel density and perfusion density determined by the built-in manufacturer software were evaluated.

Results : A significant increase in global vessel density (+1.74, SD: 2.61; p=0.009) was detected from diagnosis to 6 months. However, a reduction in this parameter was observed from 6 to 12 months (-0.92, SD: 3.04; p=0.042). Overall, a small increase in the global vessel density was observed from baseline to 12-month follow-up (+0.48, SD: 3.04; p=0.022). The mean change on the FAZ area show an increase at 6 months (+0.45, SD: 0.64, p<0.001) which subsequently declined from 6 to 12 months (-0.2, SD: 0.86; p<0.001). Similarly, to vessel density, the global results showed greater FAZ area at 12 months compared to baseline (0.28, SD:0.86, p<0.001). No statistically significant differences were found on the global perfusion parameter at one year follow up.

Conclusions : Our results suggest that in newly diagnosed Type I diabetes patients during the first 6 months the macular area suffers a transient increase in vessel density and FAZ area, which appears to decrease slightly at 12 month. Further studies are needed in order to validate these results and determine the clinical relevance of this possible self-regulated vascular remodeling process.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×